Title: Clinical study of Yunnan Baiyao combined with edaravone in treatment of acute cerebral hemorrhage
Abstract: Objective To observe the clinical efficacy on treatment of acute cerebral hemorrhage with Yunnan baiyao combined with edaravone.Methods 60 patients with acute cerebral hemorrhage were randomly divided into control group and treatment group,30 cases in each group,the control group was given conventional treatment,the treatment group was given Yunnan Baiyao combined with edaravone treatment on the basis of conventional therapy,compared the hematoma volume,neurological function deficit scores and the total efficiency in two groups before and after treatment. Results Compared before and after treatment,cranial CT hematoma volume and neurological deficit score were decreased after treatment in two groups(P 0.01);after treatment,the hematoma volume and neurogical deficit score were significantly lower than those in the control group(P 0.05),the total effectiveness in treatment group was 86.7%,the total effectiveness in control group was 73.3%,the treatment group higher than that in control group,without serious adverse reactions occuring. Conclusion Yunnanbaiyao combined with edaravone in treatment of acute cerebral hemorrhage,can significantly promote the absorption of cerebral hematoma,improve nerve function deficit,safe and effective.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot